Kreutzer, T C <br/><br/>
Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion.  [electronic resource] 

 -  The British journal of ophthalmology  Mar 2008 
 - 351-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1468-2079 
<br/><br/><label>Standard No.: </label>10.1136/bjo.2007.123513  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--administration & dosage<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Bevacizumab<br/>Drug Administration Schedule<br/>Female<br/>Fovea Centralis--pathology<br/>Humans<br/>Injections<br/>Macular Edema--drug therapy<br/>Male<br/>Middle Aged<br/>Retinal Vein Occlusion--complications<br/>Treatment Outcome<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--drug effects<br/>Vitreous Body